ICOS signaling is required for inhibition of the transcription factor Klf2, which controls expression of genes expressed by follicular T helper (Tfh) cells. When ICOS signaling is blocked, Tfh cells lose expression of characteristic Tfh genes and revert to an effector phenotype, resulting in disruption of the germinal center response.
T-follicular helper (TFH) cells represent the subpopulation of CD4+ T cells that provides help for antigen-specific B cells in the GC response. They are generated from naïve T cells during an immune response and are imprinted by their master transcription factor Bcl-6. It has been a long-standing question if TFH cells contribute to the CD4 + memory pool after the GC response has been terminated. To answer this question, we sorted antigen-specific TFH and non-TFH effector cells from an ongoing GC response and transferred them into naïve mice. Without further signals via the TCR, transferred cells rapidly contracted with a small population of both TFH and non-TFH cells surviving as memory cells in peripheral lymphoid organs for at least 4 weeks in the absence of antigen. TFH cells strongly downregulated their signature genes Bcl-6, CXCR5, and PD-1 in the memory phase. Upon rechallenge with antigen they rapidly upregulated these markers again. An enhanced potential to produce IL-21, paired with higher expression of CXCR5 and lower expression of CCR7, should enable TFH memory cells to provide more efficient help for antigen-specific B cells than their non-TFH counterparts. Immunol. 2012Immunol. . 42: 1981Immunol. -1988 a critical role for the generation of B-cell memory [3]. However, one fundamental question remains: Can TFH cells themselves survive as long-term memory cells as it has been shown for other T-cell subsets [4] or do they simply die after the GC reaction they supported has come to an end? We addressed this important question by sorting antigenspecific TFH cells directly from an ongoing GC response and transferring them into naïve mice. Memory cells derived from these TFH cells were characterized in the memory phase and after rechallenge with antigen. Keywords Results TFH cells require continuous antigen-stimulation for their maintenanceTo analyze the fate of antigen-specific TFH cells, we used an adoptive transfer system with TCR-transgenic cells from either OT-II mice [5] specific for ovalbumin or Smarta mice [6] that have a TCR recognizing a peptide from lymphocytic choriomeningitis virus (LCMV). Expression of the congenic marker Thy-1.1 on the transgenic T cells allows nonambiguous identification of even very small numbers of antigenspecific T cells and sorting of cells without cross-linking their TCR. C57BL/6 recipients of transgenic T cells were injected s.c. with the cognate antigen in CFA. In this system, upregulation of Bcl-6 within CD4 + T cells in the draining lymph node could be observed as early as 48 h after immunization (as reported by others [7,8]; data not shown). By day 5, a distinct population of cells with very high expression of PD-1 and CXCR5, two markers commonly used for defining TFH cells [9], could be clearly identified. The absolute number of TFH cells in the draining lymph node peaked around day 8 and slowly declined afterwards in parallel with the contraction of the GC response (data not shown). At day 8, the TFH phenotype should be fully imprinted and we therefore used th...
The aLb2-integrin LFA-1 (CD11a/CD18) is known as an important molecule for leukocyte migration. However, the precise role of LFA-1 in the pathogenesis of EAE has so far remained unclear. We describe here the disease development in LFA-1 À/À mice compared with WT controls. Ablation of LFA-1 resulted in more severe EAE with increased demyelination and increased numbers of myelin oligodendrocyte glycoprotein-reactive CD4
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.